SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001410578-21-000089
Filing Date
2021-11-10
Accepted
2021-11-10 16:08:57
Documents
66
Period of Report
2021-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q mrkr-20210930x10q.htm   iXBRL 10-Q 1282081
2 EX-31.1 mrkr-20210930xex31d1.htm EX-31.1 15025
3 EX-31.2 mrkr-20210930xex31d2.htm EX-31.2 14864
4 EX-32.1 mrkr-20210930xex32d1.htm EX-32.1 6674
5 EX-32.2 mrkr-20210930xex32d2.htm EX-32.2 6604
6 GRAPHIC mrkr-20210930x10q001.jpg GRAPHIC 6534
7 GRAPHIC mrkr-20210930x10q002.jpg GRAPHIC 19268
  Complete submission text file 0001410578-21-000089.txt   5052540

Data Files

Seq Description Document Type Size
8 EX-101.SCH mrkr-20210930.xsd EX-101.SCH 39558
9 EX-101.CAL mrkr-20210930_cal.xml EX-101.CAL 36947
10 EX-101.DEF mrkr-20210930_def.xml EX-101.DEF 117825
11 EX-101.LAB mrkr-20210930_lab.xml EX-101.LAB 272664
12 EX-101.PRE mrkr-20210930_pre.xml EX-101.PRE 228867
13 EXTRACTED XBRL INSTANCE DOCUMENT mrkr-20210930x10q_htm.xml XML 854935
Mailing Address 3200 SOUTHWEST FREEWAY SUITE 2500 HOUSTON TX 77027
Business Address 3200 SOUTHWEST FREEWAY SUITE 2500 HOUSTON TX 77027 (713) 400-6400
Marker Therapeutics, Inc. (Filer) CIK: 0001094038 (see all company filings)

IRS No.: 880277072 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-37939 | Film No.: 211396630
SIC: 2834 Pharmaceutical Preparations